Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. (NHI) is projected to experience a robust growth trajectory, with normalized funds from operations (FFOps) forecasted to rise by 6.7% year-over-year in 2025, followed by continued growth through 2027, suggesting a positive financial outlook. The anticipation of increased rental income related to upcoming lease expirations in skilled nursing facilities is expected to serve as a catalyst for further revenue enhancement. Additionally, the company maintains a solid pipeline of accretive investment opportunities within its segments, affirming a strong foundation for sustained financial performance moving forward.

Bears say

National Health Investors Inc. faces significant risks that may negatively impact its financial performance, particularly due to potential lower-than-expected rent resets from its NHC segment and challenges related to deferred rent collections. The company's 2026 Funds From Operations (FFO) estimates have been adjusted downward to $5.00 per share, reflecting more conservative projections, while its maintained FFO estimate of $5.03 per share remains slightly below consensus expectations. Overall, there is a concern regarding the stability of operator relationships and the potential for renewed disruptions from health crises, which could further hinder financial recovery.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $88.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $88.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.